The powder should dissolve completely, leaving a clear, colorless solution
Contraindications and Precautions Consider avoiding BPC-157 if you have: History of cancer or active malignancy Pregnancy or breastfeeding (no safety data) Competitive athletic status (WADA prohibits peptides) Known sensitivity to peptide products Severe cardiovascular disease (limited data) Blood pressure monitoring may be prudent given the nitric oxide modulation effects
Some physicians use BPC-157 only during the GLP-1 titration window (the first 3 to 4 months when GI side effects are highest), then taper off once the maintenance dose is stable and well-tolerated
Many treatments, including established forms of Peptide Therapy, have undergone extensive clinical trials to determine safe dosages and confirm their effectiveness
Typically, NAD therapy starts with a loading phase, during which injections may be administered daily or every other day for one to two weeks
Checklist for tracking personal response: Date started peptide, dose, and source Weekly notes on sleep duration and quality Skin: photos monthly, note texture and tone Energy and workout recovery ratings (110) Body composition measures monthly (weight, waist, muscle) Mood/stress journal entries twice weekly Any side effects, medications, or changes in fertility metrics Peptide therapy is typically well-tolerated with minimal side effects
